The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
โ Scribed by Seyed-Hesameddin Abbasi; Haleh Behpournia; Aboulfazl Ghoreshi; Bahman Salehi; Maedeh Raznahan; Shams-Ali Rezazadeh; Farzin Rezaei; Shahin Akhondzadeh
- Book ID
- 119364391
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 415 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0920-9964
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti
## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOIโB), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of